Sildenafil Tablet, Film Coated
Product Images NDC 71335-1005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-1005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351005)

Label Image (Lbl713351005)
This is a labeled package of Revatio, a type of Sildenafil Citrate tablet used for the treatment of pulmonary arterial hypertension. It contains 20mg of sildenafil citrate and should be stored at room temperature (20°-25°C or 68°-77°F). The package is labeled with a National Drug Code (NDC) number of 7133510051 050291125683.*
FDA Label Image

Figure-10 (Sildenafil Fig 10)

FDA Label Image

Figure-11 (Sildenafil Fig 11)

FDA Label Image

Fig-12 (Sildenafil Fig 12)

FDA Label Image

Fig-6 (Sildenafil Fig 6)

FDA Label Image

Fig-8 (Sildenafil Fig 8)

Fig-8 (Sildenafil Fig 8)
This text is a table that appears to contain information about the recommended fold change and 90% CI for various drugs and their interactions with other drugs. Some drugs require a dose adjustment while others do not. The table also shows relative change values for interacting drugs at different doses and mentions a clinical study regarding the addition of sildenafil to bosentan therapy.*
FDA Label Image

Figure-9 (Sildenafil Fig 9)

FDA Label Image

Figure-7 (Sildenafil Figure 7)

Figure-7 (Sildenafil Figure 7)
This is a table of recommended drug interactions for various drugs including Atorvastatin, Astromycin UG, Bosentan, Cimetidine, Everolimus, Bevacizumab, Oral Contraceptives, and Saquinavir. The table indicates which drugs require a dose adjustment and which do not. The last line mentions that adding sildenafil to bosentan therapy does not provide any benefits to exercise capacity.*
FDA Label Image

Str (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.